Pax5 heterozygosity (Pax5<sup>-/+</sup>), resulting in reduced PAX5 levels in mice, mimics germline or somatic PAX5 dysregulation contributing to diseases such as childhood B-cell precursor acute lymphoblastic leukemia (B-ALL). Here, PAX5 is linked to precursor B-cell acute lymphoblastic leukemia.